PR Newswire BiotechOriginal article
O'Shaughnessy Ventures Backs Bioengineer Developing Injectable Blood Vessels
Positive
AI Analysis
Summary
O'Shaughnessy Ventures awarded a fellowship to bioengineer Liam Aranda-Michel to develop an injectable blood vessel therapy that restores circulation without major surgery. This is an early-stage funding announcement for a novel therapeutic approach in vascular engineering.
Importance:2/10
Sentiment:
0.60
fundingbioengineeringinjectable therapyvascular engineeringearly stage
Related Companies
Read the original article
Published by PR Newswire Biotech on July 7, 2026 12:36 PM
